| Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses M McMahon, G O’Dell, J Tan, A Sárközy, M Vadovics, JM Carreño, ... Proceedings of the National Academy of Sciences 119 (45), e2206333119, 2022 | 39 | 2022 |
| Quality assessment of virus-like particles at single particle level: a comparative study I González-Domínguez, E Puente-Massaguer, L Cervera, F Gòdia Viruses 12 (2), 223, 2020 | 37 | 2020 |
| Application of advanced quantification techniques in nanoparticle-based vaccine development with the Sf9 cell baculovirus expression system E Puente-Massaguer, M Lecina, F Gòdia Vaccine 38 (7), 1849-1859, 2020 | 23 | 2020 |
| Nanoscale characterization coupled to multi-parametric optimization of Hi5 cell transient gene expression E Puente-Massaguer, M Lecina, F Gòdia Applied microbiology and biotechnology 102, 10495-10510, 2018 | 22 | 2018 |
| Stability enhancement of clinical grade multipotent mesenchymal stromal cell-based products C Mirabel, E Puente-Massaguer, A del Mazo-Barbara, B Reyes, P Morton, ... Journal of translational medicine 16, 1-10, 2018 | 22 | 2018 |
| A statistical approach to improve compound screening in cell culture media E Puente‐Massaguer, L Badiella, S Gutiérrez‐Granados, L Cervera, ... Engineering in life sciences 19 (4), 315-327, 2019 | 21 | 2019 |
| Integrating nanoparticle quantification and statistical design of experiments for efficient HIV-1 virus-like particle production in High Five cells E Puente-Massaguer, M Lecina, F Gòdia Applied microbiology and biotechnology 104, 1569-1582, 2020 | 20 | 2020 |
| Development of a non-viral platform for rapid virus-like particle production in Sf9 cells E Puente-Massaguer, F Gòdia, M Lecina Journal of Biotechnology 322, 43-53, 2020 | 19 | 2020 |
| Quantification of the HIV‐1 virus‐like particle production process by super‐resolution imaging: From VLP budding to nanoparticle analysis I González‐Domínguez, E Puente‐Massaguer, L Cervera, F Gòdia Biotechnology and bioengineering 117 (7), 1929-1945, 2020 | 17 | 2020 |
| PEI-mediated transient transfection of high five cells at bioreactor scale for HIV-1 VLP production E Puente-Massaguer, F Strobl, R Grabherr, G Striedner, M Lecina, ... Nanomaterials 10 (8), 1580, 2020 | 14 | 2020 |
| Influenza chimeric hemagglutinin structures in complex with broadly protective antibodies to the stem and trimer interface X Zhu, J Han, W Sun, E Puente-Massaguer, W Yu, P Palese, F Krammer, ... Proceedings of the National Academy of Sciences 119 (21), e2200821119, 2022 | 13 | 2022 |
| Accelerating HIV‐1 VLP production using stable high five insect cell pools E Puente‐Massaguer, P Grau‐Garcia, F Strobl, R Grabherr, G Striedner, ... Biotechnology Journal 16 (4), 2000391, 2021 | 13 | 2021 |
| Micrometric DNA/PEI polyplexes correlate with higher transient gene expression yields in HEK 293 cells I González-Domínguez, E Puente-Massaguer, J Lavado-García, ... New Biotechnology 68, 87-96, 2022 | 12 | 2022 |
| Coupling microscopy and flow cytometry for a comprehensive characterization of nanoparticle production in insect cells E Puente‐Massaguer, P Saccardo, N Ferrer‐Miralles, M Lecina, F Gòdia Cytometry Part A 97 (9), 921-932, 2020 | 10 | 2020 |
| Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice E Puente-Massaguer, K Vasilev, A Beyer, M Loganathan, B Francis, ... Science Advances 9 (37), eadi4753, 2023 | 5 | 2023 |
| Transduction of HEK293 cells with BacMam baculovirus is an efficient system for the production of HIV-1 virus-like particles E Puente-Massaguer, B Cajamarca-Berrezueta, A Volart, ... Viruses 14 (3), 636, 2022 | 4 | 2022 |
| Stable Sf9 cell pools as a system for rapid HIV‐1 virus‐like particle production E Puente‐Massaguer, P Grau‐Garcia, F Strobl, R Grabherr, G Striedner, ... Journal of Chemical Technology & Biotechnology 96 (12), 3388-3397, 2021 | 4 | 2021 |
| Characterization of non-neutralizing human monoclonal antibodies that target the M1 and NP of influenza A viruses WF Rijnink, D Stadlbauer, E Puente-Massaguer, NMA Okba, ... Journal of Virology 97 (11), e01646-22, 2023 | 3 | 2023 |
| Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin viruses E Puente-Massaguer, A Beyer, M Loganathan, I Sapse, JM Carreño, ... Frontiers in Bioengineering and Biotechnology 11, 1097349, 2023 | 2 | 2023 |
| The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex JL Martínez, N Lemus, TY Lai, M Mishra, I González-Domínguez, ... Vaccine 42 (14), 3365-3373, 2024 | | 2024 |
